Zydus Lifesciences LimitedNSE: ZYDUSLIFE

Zydus Lifesciences Limited Press Release May 17 2024

· Issued by Zydus Lifesciences Limited via NSE India

Filed with NSE · · 3 pages · English

Release

Zydus Lifesciences Limited has informed the Exchange regarding a press release dated May 17, 2024, titled "Zydus and MSN announces exclusive licensing and supply agreement for Cabozantinib Tablets (generic version of CABOMETYX��) for the US market".

Zydus Lifesciences Limited on 6ix

In the deck

Earlier from Zydus Lifesciences

Later from Zydus Lifesciences

All Zydus Lifesciences news releases